An in situ enzyme-linked immunosorbent assay was developed to measure in vitro development of Eimeria tenella. The assay used a polyclonal, anti-merozoite serum produced by immunization with culture-derived, chromatographically purified merozoites. Although this antiserum cross-reacted with sporozoite-infected cultures (by indirect immunofluorescence and in situ enzyme-linked immunosorbent assay), it clearly distinguished the increase in antigen synthesized throughout intracellular growth. The assay can be used for high-throughput, anticoccidial drug screening, for which it gives quantitative results that are comparable to the published radiometric ([3H]uracil incorporation) endpoint.
The demonstration that asexual stages of Eimeria tenella could be cultivated in vitro (18) made possible the design of cell culture screens to identify anticoccidial drugs. The first screens described (24) used microscopic observation to score parasite development, a method that was both laborious and qualitative. A more efficient screen endpoint has been described by Schmatz et al. (23) , who measured parasite-specific incorporation of [5,6-3H] uracil to quantitate parasite growth. The most labor-intensive step in this radiometric scoring method is the processing of samples for liquid scintillation counting. I describe an alternative scoring method using a colorimetric, in situ enzyme-linked immunosorbent assay (ELISA) which is less laborious and should further improve the efficiency of anticoccidial screening in vitro.
Although ELISAs have been applied to studies of E. tenella (3, 9, 16, 17, 21) , the methods are not adapted to measuring parasite growth. Instead, they are designed to quantitate the antibody produced in response to infection by using a fixed amount of parasite extract as an antigen. In situ ELISAs have been developed to measure in vitro growth and drug inhibition in virus-infected (1, 2, 11, 20) and protozoan-infected (6, 7, 13) monolayers. These assays detect growth of the infectious agent by measuring the antigen with a fixed amount of antibody specific for the infectious agent. This study was designed to adapt in situ ELISA methods to an E. tenella in vitro model.
MATERIALS AND METHODS
Abbreviations. BSA, Bovine serum albumin; IC50, drug concentration producing 50% inhibition of growth; MDBK, Madin-Darby bovine kidney; OD405, optical density at 405 nm; PBS, phosphate-buffered saline.
In vitro production of merozoites. MDBK cells (ATCC CCL 22) were grown in continuous culture at 40°C in 3% CO2 in nutrient mixture F12 (no. 320-1765, GIBCO Diagnostics) with 10% (vol/vol) fetal bovine serum (no. 110-1120, J. R. Scientific) and penicillin-streptomycin (no. 600-5140, GIBCO). Prior to infection, cells were subcultured into 175-cm2 flasks in RPMI 1640 (no. 320-1875, GIBCO) with 5% fetal bovine serum (RPSS). When MDBK cells had reached confluence, purified E. tenella sporozoites (22) were added at 2.5 x 105/cm2 in RP5S. After 24 h of incubation at 40°C to allow invasion, uninvaded sporozoites were removed by agitating the flask, removing the supernatant medium, and washing the monolayer once with RPSS. Fresh RP5S was added, and the cultures were incubated another 40 h, until merozoites were released into the culture medium.
Antigen and antiserum. The method for merozoite purification was similar to that developed for Plasmodium lophurae by Hollingdale and Kilejian (10) . Briefly, culture supernatants containing released merozoites were collected (1.0 x 106 to 2.5 x 106/cm2) and spun at 450 x g for 10 min to concentrate the merozoites. The pellet, containing merozoites and host cell debris, was suspended in 0.1 M NaCl-0.05 M KCI-20% BSA (no. A7284, Sigma Chemical Co.) and applied to a DE-52 (Whatman, Inc.) column equilibrated in 75 mM Tris-40 mM NaH2PO4-86 mM NaCl-100 mM glucose, pH 8.2. The merozoites that flowed through this column were evaluated for purity (removal of host cell debris) by electron microscopy (12) . Purified merozoites were suspended in PBS (no. 310-4190, GIBCO), disrupted by sonication, emulsified in Freund adjuvant (1:1, PBS-adjuvant), and injected into New Zealand White rabbits (1 x 108 to 5 x 108 merozoites per rabbit). The primary injection was intraperitoneal with complete adjuvant, and subsequent monthly boosts were subcutaneous with incomplete adjuvant. After three boosts, rabbits were bled for serum.
Indirect . After 24 h of incubation at 40°C in a humidified 3% CO2 incubator, the medium was removed, purified sporozoites were added at 4 x 104 per well in RPMI 1640 with 2% fetal bovine serum (RP2S), and incubation was continued. The inoculating dose was selected on the basis of experiments showing that when the inoculum was varied from 0.5 X 104 to 16 x 104 sporozoites per well, 4 x 104 per well gave the highest 48-h OD to 4-h OD ratio. For the stage specificity experiments, uninvaded sporozoites were washed away 4 h after inoculation. The wash was achieved by mixing the culture medium three times (by using a Cetus ProGroup liquid-handling device) to suspend sporozoites, discarding this medium, and adding 200 ,u of fresh RP2S.
(ii) Fixation. After incubation, the medium from the microtiter plates was emptied by shaking the contents out. To fix the monolayer, the wells were filled with room temperature methanol, incubated for 30 min, emptied, air dried, and stored at room temperature until the ELISA was done.
(iii) Antibody incubations. The basic ELISA buffer consisted of PBS-BSA. After 45 to 60 min of preincubation in PBS-BSA at 40°C, 100 ,u of the primary antibody solution (rabbit anti-merozoite serum diluted 1:1,600 in PBS-BSA) was added and incubated for 90 min at 40°C. Unbound primary antibody was removed by washing four times with 500 ,u1 of PBS-BSA by using the automated washing device of the Cetus ProGroup. Secondary antibody (alkaline phosphatase-conjugated goat anti-rabbit immunoglobulin G [no. A-8025, Sigma] diluted 1:1,000 in PBS-BSA; 100 ,ul) was added and incubated for 90 min at 40°C. Unbound secondary antibody was removed as for the primary antibody.
(iv) Substrate. Plates were washed once with substrate buffer (10 mM MgCl2, 50 mM Na2CO3, adjusted to pH 9.8 with HCI), and 200 ,ul of substrate (1 mg of p-nitrophenyl phosphate [no. 104-105, Sigma] per ml of substrate buffer) was added. Plates were incubated for 60 min at room temperature and then read in a microplate autoreader (model EL310, Biotek) at 405 nm. Readings were blanked against a well containing a fixed monolayer and 200 ,u1 of substrate which had been incubated in ELISA buffer without primary or secondary antibody.
[5,6-3H]uracil incorporation. Host cell plating and parasite addition were as described for the ELISA. One day after sporozoite addition, [5,6-3H] uracil (no. NET-368, Dupont, NEN Research Products) was added to 1 ,uCi/ml. At 24 h after the radiolabel addition, cultures were frozen at -70°C for 1 to 2 h. Thawing resulted in cell lysis and detachment from the plastic. The thawed cultures were harvested with a PHD harvester (model A200, Cambridge Technology), collected onto glass fiber disks (no. 240-1, Cambridge Technology), washed with water, and dried with methanol. After the addition of Aquasol-2 (NEF-952, Dupont, NEN), paper disks were counted in a model 1219 BetaRack liquid scintillation counter (LKB Instrument, Inc. contamination with host cell debris was greater and the merozoite enrichment was reduced. Under the conditions described in Materials and Methods, merozoite yield from the column has ranged from 30 to 40%. Particulate cellular debris was counted by light microscopy (x400 magnification) before and after column purification; only 3 to 5% of the material applied to the column was present in the effluent. The electron micrographs in Fig. 1 show the culture supernatants prior to DE-52 column purification (Fig. 1A) and after purification (Fig. 1B) . Merozoites directly from the culture were surrounded by lysed host cells and cellular debris. After column purification, host cell debris could be detected only after extensive scanning of the thin sections; the predominant image was of pure merozoites.
Immunofluorescent localization of antibody binding. To assist in the interpretation of ELISA results, anti-merozoite antibody binding to infected cultures was visualized by indirect immunofluorescence (Fig. 2) . Sporozoites ( Fig. 2A) showed distinct fluorescent staining, while the fluorescence associated with mature schizonts (Fig. 2B) (Fig. 3) . The Selection of an appropriate method for preparation of the monolayer appears to be an important factor for success in development of an in situ ELISA. Several methods have been described for in situ ELISAs on viable cells (8, 19) , glutaraldehyde-fixed cells (1, 2, 11, 15, 20) , Formalin-fixed cells (7) , and methanol-fixed cells (6, 13 The assay system described here may have applications beyond evaluation of intracellular development. For example, substitution of a polyclonal or monoclonal anti-sporozoite antibody in the ELISA could make it possible to detect inhibitors of sporozoite invasion in a short-incubation (e.g., (14) .
